John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
1826
Franklin Street Properties
FSP
$45.5M
| $731K | ﹤0.01% |
123,910
+58,554
| +90% | +$338K |
|
|
UBA
1827
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $730K | ﹤0.01% |
+38,800
| New | +$761K |
|
1828
Sierra Bancorp
BSRR
$512M
| $729K | ﹤0.01% |
29,174
-2,937
| -9% | -$78.4K |
|
1829
DoubleVerify
DV
$2.06B
| $728K | ﹤0.01% |
+28,910
| New | +$752K |
|
1830
CNB Financial Corp
CCNE
$1B
| $726K | ﹤0.01% |
27,598
-4,566
| -14% | -$122K |
|
1831
Highwoods Properties
HIW
$3.52B
| $726K | ﹤0.01% |
+15,864
| New | +$701K |
|
|
TUFN
1832
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $724K | ﹤0.01% |
81,116
+47,316
| +140% | +$422K |
|
1833
Primis Financial Corp
FRST
$398M
| $718K | ﹤0.01% |
51,356
-338
| -0.7% | -$5K |
|
|
ICD
1834
DELISTED
Independence Contract Drilling, Inc.
ICD
| $716K | ﹤0.01% |
173,344
+117,117
| +208% | +$461K |
|
1835
Pulmonx
LUNG
$107M
| $715K | ﹤0.01% |
+28,835
| New | +$745K |
|
1836
Hamilton Lane
HLNE
$4.63B
| $713K | ﹤0.01% |
9,226
-9,034
| -49% | -$753K |
|
1837
Orthofix Medical
OFIX
$393M
| $713K | ﹤0.01% |
+21,814
| New | +$701K |
|
|
INVX
1838
Innovex International
INVX
$2.01B
| $713K | ﹤0.01% |
19,081
-209,726
| -92% | -$6.02M |
|
1839
DHI Group
DHX
$190M
| $709K | ﹤0.01% |
119,241
-5,694
| -5% | -$32.6K |
|
1840
Green Plains
GPRE
$1.03B
| $709K | ﹤0.01% |
22,863
-6,714
| -23% | -$211K |
|
1841
Allot
ALLT
$373M
| $708K | ﹤0.01% |
87,431
+71,668
| +455% | +$653K |
|
1842
AMC Global Media
AMCX
$530M
| $704K | ﹤0.01% |
+17,316
| New | +$700K |
|
|
SMED
1843
DELISTED
Sharps Compliance Corp
SMED
| $703K | ﹤0.01% |
119,160
-60,794
| -34% | -$382K |
|
1844
Prudential
PUK
$35.3B
| $702K | ﹤0.01% |
+23,742
| New | +$758K |
|
1845
Tecnoglass Holdings
TGLS
$1.79B
| $702K | ﹤0.01% |
27,800
+2,900
| +12% | +$65K |
|
1846
DTE Energy
DTE
$28.3B
| $701K | ﹤0.01% |
5,301
-247,558
| -98% | -$30.2M |
|
1847
Ennis
EBF
$543M
| $700K | ﹤0.01% |
+37,899
| New | +$713K |
|
1848
Waste Management
WM
$88.8B
| $700K | ﹤0.01% |
4,416
-321,793
| -99% | -$48.8M |
|
1849
BancFirst
BANF
$3.73B
| $699K | ﹤0.01% |
8,400
-29,741
| -78% | -$2.31M |
|
1850
Northrim BanCorp
NRIM
$568M
| $699K | ﹤0.01% |
64,188
+8,916
| +16% | +$98.6K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.